相似文献
1
HIV among injecting drug users: current epidemiology, biologic markers, respondent-driven sampling, and supervised-injection facilities.
Curr Opin HIV AIDS. 2009 Jul;4(4):308-13. doi: 10.1097/COH.0b013e32832bbc6f.
2
HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
MMWR Surveill Summ. 2014 Jul 4;63(6):1-51.
3
HIV, hepatitis B and sexual practices in the street-recruited injecting drug users of Calcutta: risk perception versus observed risks.
Int J STD AIDS. 1998 Apr;9(4):214-8. doi: 10.1258/0956462981922061.
4
High HIV and hepatitis C prevalence amongst injecting drug users in Mauritius: findings from a population size estimation and respondent driven sampling survey.
Int J Drug Policy. 2011 Jul;22(4):252-8. doi: 10.1016/j.drugpo.2011.05.007. Epub 2011 Jun 22.
5
Risk for Heterosexual HIV Transmission Among Non-Injecting Female Partners of Injection Drug Users in Estonia.
AIDS Behav. 2013 Mar;17(3):879-88. doi: 10.1007/s10461-011-0078-9.
6
Male injecting drug users in the Deep South: bisexual behaviour is a marker for elevated HIV risk.
Int J STD AIDS. 2010 Oct;21(10):691-6. doi: 10.1258/ijsa.2010.010053.
7
High risk behavior for HIV transmission among former injecting drug users: a survey from Indonesia.
BMC Public Health. 2010 Aug 10;10:472. doi: 10.1186/1471-2458-10-472.
8
An analysis of respondent-driven sampling with injecting drug users in a high HIV prevalent state of India.
Harm Reduct J. 2017 Jul 3;14(1):41. doi: 10.1186/s12954-017-0171-0.
9
HIV infection among injecting drug users in north-east Malaysia, 1992.
AIDS Care. 1993;5(3):273-81. doi: 10.1080/09540129308258610.
10
Entry of human immunodeficiency virus infection into a population of injecting drug users, Victoria, 1990.
Med J Aust. 1991 Sep 16;155(6):378-82. doi: 10.5694/j.1326-5377.1991.tb101313.x.
引用本文的文献
1
Neurobiological Mechanisms of Action of Transcranial Direct Current Stimulation (tDCS) in the Treatment of Substance Use Disorders (SUDs)-A Review.
J Clin Med. 2025 Jul 10;14(14):4899. doi: 10.3390/jcm14144899.
2
A Correlated Network Scale-up Model: Finding the Connection Between Subpopulations.
J Am Stat Assoc. 2023;118(543):1515-1524. doi: 10.1080/01621459.2023.2165929. Epub 2023 Feb 28.
3
Acceptability of using mobile Health (mHealth) as an intervention tool for people with drug use disorders in Tanga, Tanzania.
PLOS Digit Health. 2023 Sep 27;2(9):e0000257. doi: 10.1371/journal.pdig.0000257. eCollection 2023 Sep.
4
Socio-cognitive factors influencing access to HIV prevention services among people who inject drugs in Dar es Salaam, Tanzania: An integrated bio-behavioural survey.
PLoS One. 2022 Jan 28;17(1):e0261500. doi: 10.1371/journal.pone.0261500. eCollection 2022.
5
Population estimation and harm reduction among people who inject drugs in Addis Ababa, Ethiopia.
Harm Reduct J. 2020 Sep 7;17(1):61. doi: 10.1186/s12954-020-00407-x.
6
Using respondent-driven sampling (RDS) to recruit illegal poly-substance users in Cape Town, South Africa: implications and future directions.
Subst Abuse Treat Prev Policy. 2016 Sep 1;11(1):31. doi: 10.1186/s13011-016-0074-1.
7
Induction of Potent and Long-Lived Antibody and Cellular Immune Responses in the Genitorectal Mucosa Could be the Critical Determinant of HIV Vaccine Efficacy.
Front Immunol. 2014 May 8;5:202. doi: 10.3389/fimmu.2014.00202. eCollection 2014.
8
A simulative comparison of respondent driven sampling with incentivized snowball sampling--the "strudel effect".
Drug Alcohol Depend. 2014 Feb 1;135:71-7. doi: 10.1016/j.drugalcdep.2013.11.020. Epub 2013 Dec 3.
9
HealthCall: technology-based extension of motivational interviewing to reduce non-injection drug use in HIV primary care patients - a pilot study.
AIDS Care. 2012;24(12):1461-9. doi: 10.1080/09540121.2012.663882. Epub 2012 Mar 20.
10
"Injection first": a unique group of injection drug users in Tijuana, Mexico.
Am J Addict. 2012 Jan-Feb;21(1):23-30. doi: 10.1111/j.1521-0391.2011.00194.x. Epub 2011 Dec 15.
本文引用的文献
1
Process and predictors of drug treatment referral and referral uptake at the Sydney Medically Supervised Injecting Centre.
Drug Alcohol Rev. 2008 Nov;27(6):602-12. doi: 10.1080/09595230801995668.
2
HIV prevention and psychoactive drug use: a research agenda.
J Epidemiol Community Health. 2009 Mar;63(3):191-6. doi: 10.1136/jech.2008.079301.
3
[Analysis of the epidemiologic patterns of HIV transmission in Dehong prefecture, Yunnan province].
Zhonghua Yu Fang Yi Xue Za Zhi. 2008 Dec;42(12):866-9.
4
Using hepatitis C virus and herpes simplex virus-2 to track HIV among injecting drug users in New York City.
Drug Alcohol Depend. 2009 Apr 1;101(1-2):88-91. doi: 10.1016/j.drugalcdep.2008.11.007. Epub 2008 Dec 23.
5
HIV/AIDS surveillance in Europe: update 2007.
Euro Surveill. 2008 Dec 11;13(50):19066. doi: 10.2807/ese.13.50.19066-en.
6
HIV among injecting drug users in Europe: increasing trends in the East.
Euro Surveill. 2008 Dec 11;13(50):19067. doi: 10.2807/ese.13.50.19067-en.
7
Risk factors for developing a cutaneous injection-related infection among injection drug users: a cohort study.
BMC Public Health. 2008 Dec 9;8:405. doi: 10.1186/1471-2458-8-405.
8
The cost-effectiveness of Vancouver's supervised injection facility.
CMAJ. 2008 Nov 18;179(11):1143-51. doi: 10.1503/cmaj.080808.
9
The perspectives of injection drug users regarding safer injecting education delivered through a supervised injecting facility.
Harm Reduct J. 2008 Oct 29;5:32. doi: 10.1186/1477-7517-5-32.
10
Estimates of HIV prevalence in a highly endemic area of China: Dehong Prefecture, Yunnan Province.
Int J Epidemiol. 2008 Dec;37(6):1287-96. doi: 10.1093/ije/dyn196. Epub 2008 Oct 14.
Zotero 插件